Gland Pharma Ltd. NSE: GLAND | BSE: 543245

Mid-range Performer

Download real time

1871.50 -15.30 (-0.81%)

46.46% Gain from 52W Low

146.3K

NSE+BSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

US FDA Approval

Gland Pharma gets US FDA approval for Vasopressin Injection, with a market size of $45 mn See details

Gland Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Gland Pharma Ltd. from all sources in a single place.

VOTE: Is Gland Pharma Ltd. worth buying?

215 Votes:

Buy 80.93%

Sell 9.3%

Hold 9.77%

RESEARCH REPORTS

Hold SEE REPORTS >

Buy SEE REPORTS >